L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), sold 14,785 shares at $31.43 ($467K) on 2018-03-16, disclosed to the SEC on 2018-03-16.
Open-market sale of $467k RVNC by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.65 | 2,881 | $91K | 19.5% |
| 2 | $32.80 | 1,000 | $33K | 7.0% |
| 3 | $31.43 | 5,452 | $171K | 36.7% |
| 4 | $31.43 | 5,452 | $171K | 36.7% |
| Total | $31.57 avg | 14,785 | $467K | 100% |
| Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |
| RVNC | SELL | 2017-10-20 | $401K | — | Filing → |